These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20834098)

  • 41. Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine.
    Ojwang JO; Bhattacharya BK; Marshall HB; Korba BE; Revankar GR; Rando RF
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2570-3. PubMed ID: 8585748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus.
    Lee DK; Kang JY; Shin HS; Park IH; Ha NJ
    Arch Pharm Res; 2013 Dec; 36(12):1525-32. PubMed ID: 23657805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice.
    McClary H; Koch R; Chisari FV; Guidotti LG
    J Exp Med; 2000 Jul; 192(2):289-94. PubMed ID: 10899915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune active cells with 4-1BB signal enhancement inhibit hepatitis B virus replication in noncytolytic manner.
    Wang L; Yi Y; Jiang W; Yin D; Fan J; Ye W; Zhao W
    Cell Immunol; 2018 Jun; 328():79-85. PubMed ID: 29627062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aurora kinase A promotes hepatitis B virus replication and expression.
    Jeong GU; Ahn BY
    Antiviral Res; 2019 Oct; 170():104572. PubMed ID: 31376425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular metabolism of beta-L-ddAMP-bis(tbutylSATE), a potent inhibitor of hepatitis B virus replication.
    Faraj A; Placidi L; Perigaud C; Cretton-Scott E; Gosselin G; Martin LT; Pierra C; Schinazi RF; Imbach JL; Sommadossi JP
    Nucleosides Nucleotides; 1999; 18(4-5):987-8. PubMed ID: 10432726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis B virus (HBV) replication in animal models and their applications].
    Hiasa Y; Onji M
    Nihon Rinsho; 2011 May; 69 Suppl 4():363-8. PubMed ID: 22096945
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiviral or proviral action of mycophenolic acid in hepatitis B infection?
    Pan Q; van Vuuren AJ; van der Laan LJ; Peppelenbosch MP; Janssen HL
    Hepatology; 2012 Oct; 56(4):1586-7. PubMed ID: 22407546
    [No Abstract]   [Full Text] [Related]  

  • 49. Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection.
    Hansson MJ; Moss SJ; Bobardt M; Chatterji U; Coates N; Garcia-Rivera JA; Elmér E; Kendrew S; Leyssen P; Neyts J; Nur-E-Alam M; Warneck T; Wilkinson B; Gallay P; Gregory MA
    Chem Biol; 2015 Feb; 22(2):285-92. PubMed ID: 25619934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epigenetic modulation of hepatitis B virus replication].
    Huang C; Shi GF
    Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):955-7. PubMed ID: 23570061
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS.
    Locarnini S; Guo K; Lucas R; Gust I
    Lancet; 1989 Nov; 2(8673):1225-6. PubMed ID: 2572941
    [No Abstract]   [Full Text] [Related]  

  • 52. [The difference of anti-virus effect between different modified antisense oligonucleotides in vitro].
    Zhu XY; Wang YF
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):475-6. PubMed ID: 24490308
    [No Abstract]   [Full Text] [Related]  

  • 53. IFN-γ: A Crucial Player in the Fight Against HBV Infection?
    Hillaire MLB; Lawrence P; Lagrange B
    Immune Netw; 2023 Aug; 23(4):e30. PubMed ID: 37670813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection.
    O'Brien KB; Schultz-Cherry S; Knoll LJ
    J Virol; 2011 Sep; 85(17):8680-8. PubMed ID: 21734055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant.
    Brunelle MN; Saboulard D; Massinet H; Lamant C; Soussan P; Brezillon N; Kremsdorf D
    Antivir Ther; 2010; 15(6):861-9. PubMed ID: 20834098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Williams R
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
    Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
    Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
    Morrey JD; Korba BE; Sidwell RW
    Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of novel strategies to combat hepatitis B virus targetting wild-type and drug-resistant mutants in experimental models.
    Zoulim F
    Antivir Chem Chemother; 2001; 12 Suppl 1():131-42. PubMed ID: 11594680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.